Alain Wuethrich's Biography

Alain Wuethrich, Group Leader / Researcher, The University of Queensland

Alain is currently an NHMRC Emerging Leadership Fellow, Deputy Director and Group Leader at the Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. Alain obtained his PhD from the University of Tasmania (Australia) in 2016 before transitioning into multiple postdoctoral positions at AIBN. Alain’s research interests include liquid biopsy, cancer, surface-enhanced Raman scattering, nanotechnology, and microfluidics. A key feature of his research has been the translation of discoveries at the nanoscale into innovative diagnostic technologies that enable the precise study of biomolecular aberrations in cancer, infectious diseases, and human immune system.

A Digital Nanotechnology For Lung Cancer Screening and Long COVID

Tuesday, 20 June 2023 at 12:00

Add to Calendar ▼2023-06-20 12:00:002023-06-20 13:00:00Europe/LondonA Digital Nanotechnology For Lung Cancer Screening and Long COVIDCirculating Biomarkers and Extracellular Vesicles Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Profiling circulating biomarkers has potential to deliver minimally invasive approaches for lung cancer screening and to better understand emerging diseases such as long COVID. Nanotechnology and microfluidics are well positioned to deliver innovative diagnostic systems that enable highly sensitive and multiplex analysis of circulating biomarkers. This presentation will describe a digital nanotechnology based on plasmonic barcodes and a nanostructured array for counting of single extracellular vehicles (EVs) and cytokines. We show the capability of phenotyping EVs in plasma of patients with benign and malignant lung nodules as a potential non-invasive approach for lung cancer screening. By digitally profiling trace-level cytokines at concentrations multiple orders of magnitude lower than detectable by conventional assays, we will further describe how the digital nanotechnology provided a new window into long COVID and could serve as diagnostic for this emerging disease.

Add to Calendar ▼2023-06-19 00:00:002023-06-20 00:00:00Europe/LondonCirculating Biomarkers and Extracellular Vesicles Europe 2023Circulating Biomarkers and Extracellular Vesicles Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors